amimestrocel (hUC-MSC PLEB001)
/ Platinumlife Biotech
- LARVOL DELTA
Home
Next
Prev
1 to 4
Of
4
Go to page
1
June 30, 2025
MSC-DKD-001: Safety and Efficacy of Mesenchymal Stromal Cells (Amimestrocel ) in Diabetic Kidney Disease
(clinicaltrials.gov)
- P2 | N=120 | Recruiting | Sponsor: Chinese PLA General Hospital | Not yet recruiting ➔ Recruiting
Enrollment open • Diabetic Nephropathy • Nephrology • Renal Disease
July 01, 2025
MSC-AKI-001: Clinical Study to Evaluate the Efficacy and Safety of Mesenchymal Stromal Cells (Amimestrocel ) in Patients With Acute Kidney Injury
(clinicaltrials.gov)
- P2 | N=50 | Recruiting | Sponsor: Chinese PLA General Hospital | Not yet recruiting ➔ Recruiting
Enrollment open • Acute Kidney Injury • Nephrology • Renal Disease
May 14, 2025
MSC-DKD-001: Safety and Efficacy of Mesenchymal Stromal Cells (Amimestrocel ) in Diabetic Kidney Disease
(clinicaltrials.gov)
- P2 | N=120 | Not yet recruiting | Sponsor: Chinese PLA General Hospital
New P2 trial • Diabetic Nephropathy • Nephrology • Renal Disease
May 03, 2025
MSC-AKI-001: Clinical Study to Evaluate the Efficacy and Safety of Mesenchymal Stromal Cells (Amimestrocel ) in Patients With Acute Kidney Injury
(clinicaltrials.gov)
- P2 | N=50 | Not yet recruiting | Sponsor: Chinese PLA General Hospital
New P2 trial • Acute Kidney Injury • Nephrology • Renal Disease
1 to 4
Of
4
Go to page
1